Skip to main content
BMC is moving to Springer Nature Link. Visit this journal in its new home.
Fig. 2 | BMC Veterinary Research

Fig. 2

From: PARP inhibitor olaparib induces DNA damage and acts as a drug sensitizer in an in vitro model of canine hematopoietic cancer

Fig. 2
See More

Histograms presenting percentages of proliferating (Ki-67 positive cells). Cells after 48-hour treatment with 25 and 50 µM of olaparib with reference to the control (A). Graphs displaying the statistical analysis of the results (B). Values are presented as means ± standard deviation (SD) of three independent experiments

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us